ReviewJournal of diabetes research2026
From a Shared Stress to Cell-Type-Specific Responses: The Heterogeneous Mechanisms of High Glucose-Induced Cellular Senescence in Diabetic Kidney Disease.
Review in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Diabetic kidney disease (DKD) is a severe microvascular complication of diabetes characterized by complex pathogenesis in which renal cellular senescence is a critical pathological element. Traditionally, hyperglycemia has been regarded as a uniform stressor inducing cellular senescence; however, significant heterogeneity exists in different renal cell types' responses to high glucose (HG) stimulation. This review systematically elucidates mechanisms underlying senescence of major renal cell types under hyperglycemic conditions. Hyperglycemia acts as a common initiator triggering senescence via shared pathways, including oxidative stress and metabolic dysregulation. However, owing to distinct structural, functional, and molecular profiles across cell types, divergent senescence programs are activated. Specifically, podocyte senescence centers on GSK3β-mediated collapse of metabolic homeostasis and GPR124 axis-related mechanosensing dysfunction; mesangial cell (MC) senescence manifests as STAT5- and Caveolin-1 signaling-mediated "senescence-fibrosis" vicious cycles; glomerular endothelial cell (GEC) senescence is characterized by dysregulation of the NOS/NO signaling axis and glycocalyx damage; and renal tubular epithelial cell (TEC) senescence is initiated by mitochondrial damage under metabolic overload, promoting interstitial fibrosis through the senescence-associated secretory phenotype (SASP). By revealing this heterogeneous mechanism shifting from "common stress" to "specific responses," this review offers a novel perspective on DKD pathogenesis and establishes a theoretical foundation for developing targeted anti-senescence therapies. It further discusses implications for the clinical translation of renal protective agents.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.